Literature DB >> 23076682

Atypical fractures do not have a thicker cortex.

V A Koeppen1, J Schilcher, P Aspenberg.   

Abstract

UNLABELLED: An association between atypical fractures and general cortical thickness of the femoral shaft is often suggested in the literature. Our radiographic measurements of 59 atypical and 218 ordinary fractures now exclude a difference larger than 10 % in mean femoral cortical thickness (sum of lateral and medial) with 95 % confidence.
INTRODUCTION: An increased general cortical thickness in patients with fatigue fracture of the femoral shaft (atypical fractures) is commonly suggested. However, there are scarce data to support this.
METHODS: In a published nationwide Swedish study, we identified by radiographic review 59 women with an atypical fracture during 2008. The femoral cortical thickness index (thickness/femoral diameter) of these women was now compared with the 218 ordinary fractures that occurred in the same region of the femur in a case-control design. The cortical thickness index 5 cm below the lesser trochanter was the primary variable.
RESULTS: Patients with atypical fractures were younger. Without correction for age, they had a thicker cortex (i.e., higher index). However, the difference in cortical thickness disappeared after age correction. The 95 % CI excludes a group mean difference exceeding 10 % of total mean thickness. Similarly, there was no significant difference in cortical thickness between patients with or without bisphosphonate treatment or between the ipsi- and contralateral femurs in patients with an atypical fracture.
CONCLUSION: The concept of a generally increased cortical thickness in patients with atypical fractures should be reconsidered.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23076682     DOI: 10.1007/s00198-012-2173-9

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  11 in total

1.  Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features.

Authors:  Andrea Giusti; Neveen A T Hamdy; Olaf M Dekkers; Sharita R Ramautar; Sander Dijkstra; Socrates E Papapoulos
Journal:  Bone       Date:  2010-12-31       Impact factor: 4.398

2.  Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Peter R Ebeling; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David Dempster; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Kenneth Koval; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Howe Tet Sen; Marjolein C H van der Meulen; Robert S Weinstein; Michael Whyte
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

3.  Clinical correlates of atypical femoral fracture.

Authors:  Joan C Lo; Susie Y Huang; Grace A Lee; Stutee Khandelwal; Stutee Khandewal; Jason Provus; Bruce Ettinger; Joel R Gonzalez; Rita L Hui; Christopher D Grimsrud
Journal:  Bone       Date:  2012-03-04       Impact factor: 4.398

4.  Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.

Authors:  Nicola Napoli; Jenny Jin; Katherine Peters; Rosanna Wustrack; Shane Burch; Aldric Chau; Jane Cauley; Kristine Ensrud; Michael Kelly; Dennis M Black
Journal:  J Clin Endocrinol Metab       Date:  2012-04-30       Impact factor: 5.958

5.  Bisphosphonate use and atypical fractures of the femoral shaft.

Authors:  Jörg Schilcher; Karl Michaëlsson; Per Aspenberg
Journal:  N Engl J Med       Date:  2011-05-05       Impact factor: 91.245

6.  Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.

Authors:  René Rizzoli; Michel Laroche; Marc-Antoine Krieg; Isolde Frieling; Thierry Thomas; Pierre Delmas; Dieter Felsenberg
Journal:  Rheumatol Int       Date:  2010-05-29       Impact factor: 2.631

7.  An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

Authors:  Ernest Beng Kee Kwek; Seo Kiat Goh; Joyce Suang Bee Koh; Meng Ai Png; Tet Sen Howe
Journal:  Injury       Date:  2008-01-28       Impact factor: 2.586

8.  Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.

Authors:  B A Lenart; A S Neviaser; S Lyman; C C Chang; F Edobor-Osula; B Steele; M C H van der Meulen; D G Lorich; J M Lane
Journal:  Osteoporos Int       Date:  2008-12-09       Impact factor: 4.507

9.  Correlation of plain radiographic indices of the hip with quantitative bone mineral density.

Authors:  A P Sah; T S Thornhill; M S LeBoff; J Glowacki
Journal:  Osteoporos Int       Date:  2007-03-06       Impact factor: 4.507

Review 10.  Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Authors:  R Rizzoli; K Akesson; M Bouxsein; J A Kanis; N Napoli; S Papapoulos; J-Y Reginster; C Cooper
Journal:  Osteoporos Int       Date:  2010-11-18       Impact factor: 4.507

View more
  12 in total

1.  Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.

Authors:  Laura E Targownik; Andrew L Goertzen; Yunhua Luo; William D Leslie
Journal:  Am J Gastroenterol       Date:  2016-11-15       Impact factor: 10.864

Review 2.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

3.  Atypical femoral fractures, bisphosphonates, and mechanical stress.

Authors:  Per Aspenberg; Jörg Schilcher
Journal:  Curr Osteoporos Rep       Date:  2014-06       Impact factor: 5.096

4.  Which AO/OTA 31-A2 pertrochanteric fractures can be treated with a dynamic hip screw without developing a lateral wall fracture? A CT-based study.

Authors:  Gaurav Sharma; Ravijot Singh; Kiran Kumar Gn; Vaibhav Jain; Ankit Gupta; Shivanand Gamanagatti; Kamran Farooque; Vijay Sharma
Journal:  Int Orthop       Date:  2015-07-04       Impact factor: 3.075

5.  Mandibular inferior cortical bone thickness on panoramic radiographs in patients using bisphosphonates.

Authors:  Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Michelle Lloid; Shane Patrick Drew; Mark M Schubert
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-02-14

6.  Sensitivity and specificity of radiographic characteristics in atypical femoral fractures.

Authors:  A L Adams; F Xue; J Q Chantra; R M Dell; S M Ott; S Silverman; J C Giaconi; C Critchlow
Journal:  Osteoporos Int       Date:  2016-10-21       Impact factor: 4.507

7.  Factors associated with atypical femoral fracture.

Authors:  Dam Kim; Yoon-Kyoung Sung; Soo-Kyung Cho; Minkyung Han; Yee-Suk Kim
Journal:  Rheumatol Int       Date:  2015-07-23       Impact factor: 2.631

8.  Absence of femoral cortical thickening in long-term bisphosphonate users: implications for atypical femur fractures.

Authors:  Foster Chen; Zhong Wang; Timothy Bhattacharyya
Journal:  Bone       Date:  2014-01-25       Impact factor: 4.398

9.  The effect of alendronate treatment on cortical thickness of the proximal femur in postmenopausal women.

Authors:  Maryam Mobini; Leyla Dehghan; Gholamali Yosefi; Alireza Mohammadpour; Rohollah Abdi
Journal:  Med J Islam Repub Iran       Date:  2016-02-15

10.  Dichotomous location of 160 atypical femoral fractures.

Authors:  Veronika A Koeppen; Jörg Schilcher; Per Aspenberg
Journal:  Acta Orthop       Date:  2013-11-29       Impact factor: 3.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.